Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,355 | -33,548 | 11,109 | -37,090 | -38,542 |
| Depreciation Amortization | 4,446 | 2,006 | 7,138 | 5,726 | 3,559 |
| Income taxes - deferred | -2,253 | -895 | -35,679 | 54,445 | -3,064 |
| Accounts payable and accrued liabilities | -326 | -1,825 | 1,592 | 4,572 | -1,063 |
| Other Working Capital | -3,913 | -6,553 | -17,438 | 3,747 | -5,216 |
| Other Operating Activity | 64,316 | 16,852 | -65,902 | -85,728 | 2,662 |
| Operating Cash Flow | $-46,085 | $-23,963 | $-99,180 | $-54,328 | $-41,664 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -5,000 | -3,000 |
| PPE Investments | -2,812 | -448 | -10,972 | -9,371 | -6,783 |
| Net Acquisitions | N/A | N/A | -5,557 | -557 | -557 |
| Investing Cash Flow | $-2,812 | $-448 | $-16,529 | $-14,928 | $-10,340 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 39,435 | 1,586 | 49,916 | N/A | N/A |
| Debt Repayment | N/A | N/A | -53,157 | -21,500 | -21,500 |
| Common Stock Issued | 58,435 | 49,113 | 57,928 | 47,674 | 45,628 |
| Other Financing Activity | -22,466 | -22,466 | -1,012 | -1,012 | -1,012 |
| Financing Cash Flow | $75,404 | $28,233 | $53,675 | $25,162 | $23,116 |
| Exchange Rate Effect | -152 | 1 | 65 | 19 | 171 |
| Beginning Cash Position | 20,429 | 20,429 | 82,398 | 82,398 | 82,398 |
| End Cash Position | 46,784 | 24,252 | 20,429 | 38,323 | 53,681 |
| Net Cash Flow | $26,355 | $3,823 | $-61,969 | $-44,075 | $-28,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,085 | -23,963 | -99,180 | -54,328 | -41,664 |
| Capital Expenditure | -2,812 | -448 | -10,972 | -9,371 | -6,783 |
| Free Cash Flow | -48,897 | -24,411 | -110,152 | -63,699 | -48,447 |